Vistara Welcomes Chris Angelatos

Vistara News
Chris Angelatos - Vistara Growth

Vistara Growth is pleased to welcome Chris Angelatos as the newest member of the investment team. Joining us as a Senior Associate in our Toronto office, Chris comes to Vistara with experience as an entrepreneur, technology investment banker, and most recently as a venture investor focused on the healthcare sector.

Over the past 3 years, Chris sourced and executed global investments in Healthcare IT and related technology-enabled healthcare services companies and provided strategic advice and guidance to those portfolio companies.

Before becoming an investor, Chris began his career as a startup founder, developing and launching an innovative consumer product business. He then went on to work on the CIBC Mid-Market Technology and Innovation Investment Banking team, where he focused on growth equity and M&A transaction advisory for private technology companies.

At Vistara, Chris will leverage his unique blend of entrepreneurial, technical, industry and financial acumen for the benefit our portfolio companies in healthcare and across other key verticals of expertise.

About Vistara Growth

Vistara Growth provides highly flexible growth debt and equity solutions to leading technology companies across North America. Founded, managed, and funded by seasoned technology finance and operating executives, “Vistara” (Sanskrit for “expansion”) is focused on enabling growth for the ambitious entrepreneurs we invest in, our investors, our people, and the communities we operate in.  For more information, send us a message by contacting us here.

Looking for Flexible Growth Capital?

Read our case studies to learn how our growth debt and equity solutions have enabled our founders and helped our portfolio companies.

Skytap Secures $18 Million Financing From Vistara Growth
Beedie Luminaries 2024 Cohort Scholarships: Applications Now Open

Connect:

Subscribe

We’ll update you when new resources come available.

Name(Required)
This field is hidden when viewing the form
Newsletter Signup
This field is for validation purposes and should be left unchanged.